spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Valeo 

 HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Apr 2021
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 18 Jan 2021
Valeo Pharma Announces Major Addition to its Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2020
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Nov 2020
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
Biopharmaceuticals Regulatory Product Launch
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Nov 2016
Amedica Announces New Sales Leadership and Provides Regulatory Updates
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 25 Jan 2016
Amedica Enhances Valeo II(TM) Product Family With the Addition of Its Second Generation Cervical System
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 14 Jul 2015
EDAP Names Francois Dietsch Chief Financial Officer
Devices Oncology Personnel
 HSMN NewsFeed - 12 Feb 2015
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers With Porous Silicon Nitride Center
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Sep 2013
invendo medical Appoints Chief Operating And Chief Technology Officer
Devices Gastroenterology Personnel
 HSMN NewsFeed - 22 Mar 2013
Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 Implantations
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 29 Jan 2013
Amedica Announces Expansion Of Executive Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 12 Jul 2011
Celsion Announces Management and Board Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery
 HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2009
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Nov 2008
Amedica Receives CE Mark for the World's First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System
Devices Neurosurgery Orthopaedic Regulatory
 HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Dec 2007
Amedica Receives FDA Special 510(k) Clearance for its Valeo(TM) Ceramic Spinal Implant
Devices FDA Orthopaedic Neurosurgery
 HSMN NewsFeed - 26 Nov 2007
Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 31 Oct 2007
Amedica Receives FDA 510(k) Clearance for Valeo(TM) Cervical Plate
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Jan 2007
Antares ATD(TM) Formulation Enters Phase III Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 18 Dec 2006
Antares Receives First FDA Approval of ATD(TM) Gel Platform
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2006
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
Devices Neurosurgery Personnel
 HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2006
Antares Submits 510(k) with a Branded Human Growth Hormone
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Jul 2006
OraSure Technologies Appoints Senior Vice President, Business Development
Diagnostics Personnel
 HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Biopharmaceuticals Devices Drug Delivery Licensing
 HSMN NewsFeed - 26 Jun 2006
Antares Reports On End of Phase II Meeting with FDA for Anturol(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 24 Apr 2006
Antares Pharma Announces New Proprietary Dermatological Drug Delivery System
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 21 Apr 2006
Antares Announces FDA Acceptance of Licensee's NDA
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Feb 2006
Antares Pharma Announces Appointment of Robert F. Apple as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2006
Antares Completes the Phase II Clinical Trial for Anturol(TM)
Biopharmaceuticals Drug Delivery
Return to NewsFeed  

 Additional items found! 18

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 18 additional stories matching:
Valeo
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.